Background: The present study aim to comprehensively report the epidemiological and clinical characteristics of the COVID-19 patients and to develop a multi-feature fusion model for predicting the critical ill probability.Methods: It was a retrospective cohort study that incorporating the laboratory-confirmed COVID-19 patients in the Chongqing Public Health Medical Center. The prediction model was constructed with least absolute shrinkage and selection operator (LASSO) logistic regression method and the model was further tested in the validation cohort. The performance was evaluated by the receiver operating curve (ROC), calibration curve and decision curve analysis (DCA).Results: A total of 217 patients were included in the study. During the treatment, 34 patients were admitted to intensive care unit (ICU) and no developed death. A model incorporating the demographic and clinical characteristics, imaging features and laboratory findings were constructed to predict the critical ill probability and it was proved to have good calibration, discrimination ability and clinic use.Conclusions: The prevalence of critical ill was relatively high and the model may help the clinicians to identify the patients with high risk for developing the critical ill, thus to conduct timely and targeted treatment to reduce the mortality rate.
Tuberculosis (TB) remains the leading cause of death among people living with HIV (PLWH) despite effective antiretroviral therapy (ART), with HIV infection increasing the risk of active TB by 16 to 27-fold. Even among virologically suppressed individuals on ART, the risk remains 4 to 7-fold higher than in HIV-negative populations, indicating that mechanisms beyond CD4+ T-cell depletion contribute to persistent TB susceptibility. Autophagy is a conserved lysosomal degradation pathway essential for intracellular pathogen clearance and immune regulation, and its dysregulation has emerged as a critical determinant of host-pathogen interactions in HIV/TB co-infection. In this review, we synthesize current evidence suggesting that HIV profoundly suppresses autophagy in key immune cells through the concerted actions of viral proteins, including Nef, Tat, and Env, through the off-target effects of ART drugs. This inhibition may disrupt macrophage antimicrobial functions, including phagosome maturation, xenophagy, and LC3-associated phagocytosis, while also impairing antigen presentation in dendritic cells. These defects may compromise communication between immune cells, attenuate T-cell responses, and create a permissive intracellular niche for Mycobacterium tuberculosis (Mtb) survival and proliferation. We propose an integrated mechanistic framework linking HIV-driven autophagy suppression to enhanced TB susceptibility, highlighting the synergistic interplay between HIV proteins and Mtb evasion strategies. By elucidating these molecular connections, we identify autophagy as a promising therapeutic target and highlight autophagy-directed host-directed therapies as a potential strategy to reduce the persistent TB burden in PLWH and advance toward a cure for both infections.